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Abstract
Turkesterone is a phytoecdysteroid possessing an 11α-hydroxyl group. It is an analogue of the insect steroid hormone 20-hydroxyecdysone.
Previous ecdysteroid QSAR and molecular modelling studies predicted that the cavity of the ligand binding domain of the ecdysteroid
receptor would possess space in the vicinity of C-11/C-12 of the ecdysteroid. We report the regioselective synthesis of a series of
turkesterone 11α-acyl derivatives in order to explore this possibility. The structures of the analogues have been unambiguously determined
by spectroscopic means (NMR and low-resolution mass spectrometry). Purity was verified by HPLC. Biological activities have been
determined in Drosophila melanogaster B II cell-based bioassay for ecdysteroid agonists and in an in vitro radioligand-displacement
assay using bacterially-expressed D. melanogaster EcR/USP receptor proteins. The 11α-acyl derivatives do retain a significant amount
of biological activity relative to the parent ecdysteroid. Further, although activity initially drops with the extension of the acyl chain
length (C2 to C4), it then increases (C6 to C10), before decreasing again (C14 and C20). The implications of these findings for the interaction
of ecdysteroids with the ecdysteroid receptor and potential applications in the generation of affinity-labelled and fluorescently-tagged
ecdysteroids are discussed.
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Abbreviation:
CoMFA comparative molecular field analysis
DCM dichloromethane
DMF dimethylformamide
DMP 2,2-dimethoxypropane
4D-QSAR 4-dimensional quantitative structure-activity relationship
EcR ecdysteroid receptor
EcRE ecdysteroid response element
HPLC high-performance liquid chromatography
LBD ligand-binding domain
NMR nuclear magnetic resonance
ponA ponasterone A
QSAR quantitative structure-activity relationship
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SAR structure-activity relationship
SPE solid-phase extraction
THF tetrahydrofuran
TLC thin-layer chromatography
p-TsOH para-toluenesulphonic acid
USP ultraspiracle
UV-VIS ultraviolet-visible
Abbreviations continued from previous page.
Introduction
Ecdysteroids are the steroid hormones of arthropods and
possibly of other invertebrate phyla too. They also occur in certain
plant species, where they are known as phytoecdysteroids and are
believed to contribute to the deterrence of invertebrate predators
(Dinan, 2001). In insects, they regulate moulting and metamorphosis
and have been implicated in the regulation of reproduction, diapause
etc. (Koolman, 1989). Most actions of ecdysteroids are mediated
by intracellular receptor complexes, which regulate gene expression
in a tissue- and development-specific manner. In Drosophila
melanogaster, the receptor complex consists of the ecdysteroid
receptor (EcR) protein, of which there are 3 isoforms (Koelle et al.,
1991; Talbot et al., 1993), and the Ultraspiracle (Usp) protein, which
is a homologue of the vertebrate retinoid X receptor (RXR) protein
(Oro et al., 1990). Both EcR and Usp are members of the nuclear
receptor superfamily (Laudet, 1997). EcR binds ligand with high
affinity only when it is complexed to Usp (Yao et al., 1993). It is
not known for certain if there is a natural ligand for Usp, although it
has been suggested that juvenile hormone might be a possible
candidate (Jones and Jones, 2000). Owing to the critical role that
the ecdysteroid system plays in regulating insect development, there
is considerable interest in characterising ligand/receptor/EcRE
interactions from different insect Orders and to exploit the
differences to develop Order-specific pest control agents. The
selectivity of the bisacylhydrazines, non-steroidal agonists, is a good
example of what can be achieved (Dhadialla et al., 1998). Further,
because the ecdysteroid receptor is specific to invertebrates and
ecdysteroids appear to be non-toxic to vertebrates and plants (Sláma
and Lafont, 1995), there is growing interest in the use of ecdysteroid
systems in transgenic gene-switch systems in vertebrate or plant
cells to generate medically or agronomically effective systems
(Fussenegger, 2001; Lafont and Dinan, 2003 ).
In recent years, we have conducted an extensive SAR for
ecdysteroids in a homogeneous bioassay system, based on the
ecdysteroid-responsive l(2)mbn (BII) permanent cell line of
Drosophila melanogaster (Clément et al., 1993). The response of
these cells reflects the affinity of the EcR/USP complex for the
ecdysteroid analogue and can be measured in a simple microplate-
based assay. In conjunction with molecular modelling methods
(CoMFA and 4D-QSAR; Dinan et al., 1999; Ravi et al., 2001), SAR
of an extensive range of pure ecdysteroid analogues has provided
testable predictions for ecdysteroid interaction with the LBD and
generated the first pharmacophore hypothesis for ecdysteroid
binding. Amongst the predictions to come out of the CoMFA/4D-
QSAR analyses was that a region capable of accommodating steric
bulk was present around the location of C-11/C-12 of the ecdysteroid
molecule. We have tested this hypothesis by generating a series of
11α-acyl derivatives of the phytoecdysteroid turkesterone (Figure
1: structure 1) and determining their biological activities relative to
the parent ecdysteroid.
Materials and Methods
Chemicals
Turkesterone (1) was isolated from Ajuga turkestanica
(Usmanov et al., 1975). 20-Hydroxyecdysone (6) was supplied by
Dr. V. Volodin (Institute of Biology, Russian Academy of Sciences).
Muristerone A (9) was purchased from Simes spa, Italy. Other
ecdysteroids were generous gifts from other researchers (see
acknowledgements in Dinan et al., 1999). Acyl anhydrides were
purchased from Sigma/Aldrich. Solvents were analytical or HPLC-
Figure 1. Structures of selected ecdysteroids. See Figure 2 for structures of
further ecdysteroids mentioned in the text.
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grade and used without further purification, with the exception of
pyridine, which was dried over sodium hydroxide pellets for at least
24 h before use. All other chemicals were obtained from Sigma-
Aldrich Co. (Poole, Dorset, U.K.) or Lancaster Synthesis
(Morecambe, Lancs., U.K.).
NMR
1H and 13C nuclear magnetic spectroscopy was performed
on a Varian Unity 300 spectrometer (at CSIC, Barcelona) or on a
Bruker DMX500 MHz spectrometer (NMR Service, University of
Barcelona). Samples were dissolved in the indicated solvent.
Chemical shifts are given in ppm and the coupling constants and
widths at half height (ω1/2) are given in Hz. Spectral assignments
were achieved by comparison to published data where available
(Lafont et al., 2002).
Mass spectrometry
CIMS and FABMS spectra were recorded at the Ecole
Normale Supérieure (Paris, France) on a Jeol MS 700 spectrometer
equipped with a direct inlet probe. CIMS spectra were recorded in
chemical ionisation/desorption mode using ammonia as the reagent
gas.
UV spectrophotometry
Ultra-violet spectra of ecdysteroids were determined in
methanol using a Shimadzu UV-2401 PC UV-VIS dual-beam
spectrophotometer and quartz cells (Hellma, Essex, U.K.). Extinction
coefficients were obtained from Lafont et al. (2002).
Thin-layer chromatography
TLC was performed on Merck 60 F254 pre-coated 10 x 10
cm plates (BDH, Poole, U.K.), with CHCl3/EtOH (9:1 v/v) for
development and visualisation by fluorescence quenching under
short-wavelength UV light.
Solid-phase extraction
Reversed-phase (C18; 0.5g) Sep-Pak cartridges (Waters/
Millipore, Watford, U.K.) were activated with methanol (5 mL),
followed by water (10 mL). The sample was applied in 10% aq.
MeOH and then the column was sequentially eluted with 5 mL
portions of 10%, 25% and 100% aq. MeOH.
HPLC
Two HPLC systems were employed. The analytical system
consisted of a Gilson model 811 HPLC coupled with a Gilson 160
diode-array detector and controlled by Gilson Unipoint program.
The semi-preparative system consisted of two Gilson model 303
pumps, a model 802c manometric module, a mixing unit, a
Holochrome variable wavelength detector and Rheodyne 7125
injector block. Solvent composition and flow was controlled by an
Apple IIe computer with Gilson Gradient Manager program. Elution
profiles were monitored at 242 nm. Three types of column were
used: i) Spherisorb reversed-phase octadecyl (ODS2) column
(analytical: 150 mm x 4.6 mm i.d., 5 µm particle size; semi-
preparative: 250 mm x 10 mm i.d. 5 µm particle size), ii) normal-
phase Zorbax SIL column (analytical: 250 mm x 4.6 mm i.d. 5 µm
particle size), iii) normal-phase Apex II DIOL column (analytical:
250 mm x 4.6 mm i.d., 5 µm particle size). Columns were purchased
from Jones Chromatography, Hengoed, Wales.
Synthesis of 11α-acyl derivatives of turkesterone
Conversion of turkesterone (1) to 2,3-isopropylidene turkesterone
20,22-phenylboronate (12)
The procedure was modified from Guédin-Vuong et al.
(1985). A solution of turkesterone (10 mg; 20.8 µmol) and
phenylboronic acid (2.7 mg, 22.1 µmol; 1.1 eq) in dry DMF (500
µL) was stirred at room temperature for two hours. Dry acetone
(3.5 mL), dry DMP (200 µL) and fused p-TsOH (1 mg; 10.4 µmol;
0.5 eq) were then added and the reaction was stirred for a further 3
hours. Acetone and DMP were evaporated under nitrogen and 2
mL ethyl acetate was added to the remaining DMF. This mixture
was partitioned three times with saturated aqueous sodium chloride
solution leaving the 2,3-isopropylidene turkesterone 20,22-
phenylboronate in the ethyl acetate phase. The product was assessed
for purity by TLC (CHCl3/EtOH 9:1, v/v, Rf 12: 0.52; cf Rf 1: 0.04)
and used without further purification or assessment of yield. This
reaction was repeated many times with acyl derivatization at C-
11α occurring as a third step without complete purification of the
Table 1. 1H NMR data for turkesterone and turkesterone acetates. Spectra
were obtained in CDCl3 on a Varian Unity 300 spectrometer (300 MHz).
*Data taken from Vokác et al. (1998; in CD3OD)
#Spectra obtained on a Bruker DMX500 spectrometer (500 MHz) (solvent
signal centered at δ 7.24 [at 7.27 for the Varian spectrometer]).
1* 2 4 5#
1ax-H 1.38 1.40
1eq-H 2.59 1.66
2ax-H 4.01 5.13 5.28 4.04
3eq-H 3.95 4.11 4.18 4.07
4ax-H 1.78 1.66
4eq-H 1.68 1.86
5-H 2.33 2.52 2.40
7-H 5.80 5.87 5.93d 5.89d
9-H 3.15 3.09 3.42 3.30
11-H 4.10 4.11 5.28 5.29
12ax-H 2.22 2.35
12eq-H 2.16 2.05
15a-H 1.95 2.06
15b-H 1.58 1.58
16a-H 2.00 2.00
16b-H 1.75 1.87
17-H 2.43 2.35
18-Me 0.88 0.878 0.925 0.884
19-Me 1.06 1.115 1.094 1.043
21-Me 1.19 1.257 1.216 1.246
22-H 3.32 3.44 3.42 4.83
23a-H 1.66 1.48
23b-H 1.29 1.68
24a-H 1.80 1.46
24b-H 1.43 1.38
26-Me 1.21 1.274 1.273 1.212
27-Me 1.22 1.274 1.268 1.189
Acetyl-CH3 - 2.098 2.100 2.102
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intermediates.
Conversion of 2,3-isopropylidene turkesterone 20,22-
phenylboronate (12) to 2,3-isopropylidene turkesterone (10)
To a solution of 2,3-isopropylidene turkesterone 20,22-
phenylboronate (12: synthesised from 10 mg turkesterone 1) in a
(9:1) mixture of THF/H2O (2 mL) was added H2O2 (30 %; 1 mL),
which had been previously adjusted to pH 7 with 0.1M NaOH. This
mixture was stirred at room temperature for 2 hours. The reaction
was quenched by the addition of H2O (2 mL) and the THF was
removed under reduced pressure. The residue was purified through
a 0.5 g C18 reversed-phase Sep-Pak cartridge and assessed on TLC
(CHCl3/EtOH, 9:1, v/v; Rf 10: 0.24, cf Rf 12: 0.52). The product
could be used directly in acetylation reactions without further
purification.
Conversion of 2,3-isopropylidene turkesterone 20,22-
phenylboronate (12) to 11α-acyl turkesterone (14)
i) turkesterone 11α-acetate (14a)
To a solution of 2,3-isopropylidene turkesterone 20,22-
phenylboronate (12: synthesised from 5 mg turkesterone [1]) in dry
pyridine (800 µL) at room temperature was added acetic anhydride
(400 µL). The reaction was stirred at room temperature for 1 hour
and quenched with the addition of H2O (20 mL). The reaction
mixture was pre-purified on a SPE cartridge and the 100% MeOH
fraction was dried under nitrogen. The residue was dissolved in
dioxan (700 µL) and aqueous HCl (0.1M, 700 µL) was added
dropwise. The reaction mixture was stirred at room temperature for
4 hours and diluted with H2O (20 mL). The product was pre-purified
on a SPE cartridge and analysed by HPLC using an ODS2 analytical
column with detection at 242 and 300 nm (30 %-100 % MeOH
linear gradient over 30 minutes; 1 mL/min; Rt (12) = 24.4 min, Rt
(14a) = 8.3 min). The product was purified on an ODS2 semi-
preparative column (MeOH/H2O [45:55 v/v], 2 mL/min) and yielded
turkesterone 11α-acetate (14a: 1.61 mg; 3.0 µmol; 30% yield).
CIMS: 556 ([M+NH4]+, 18%), 538 ([M]+, 3%), 521 ([M+H-H2O]+,
10%), 503 ([M+H-2H2O]+, 8%), 479 ([M+H-AcOH]+, 100%), 461
([M+H-AcOH-H2O]+, 34%), 443 ([M+H-AcOH-2H2O]+, 13%), 425
(6%), 345 (9%)
1H and 13C NMR: see Tables 3 and 4.
ii) turkesterone 11α-propionate (14b)
To a solution of 2,3-isopropylidene turkesterone 20,22-
phenylboronate (12: synthesised from 5 mg turkesterone [1]) in dry
pyridine (800 µL) at room temperature was added propionic
Table 2. 13C NMR data for turkesterone and turkesterone acetates. Spectra
were obtained in CDCl3 on a Varian Unity 300 spectrometer (75 MHz).
*Data taken from Vokác et al. (1998)
# # # # # spectra obtained in CDCl3/Pyr
Table 3. 1H NMR data for turkesterone 11α-acyl analogues. Spectra were
obtained in CDCl3 on a Varian Unity 300 spectrometer (300 MHz), unless
otherwise indicated
# Spectra obtained on a Bruker Advance DRX400 spectrometer (400 MHz)
*Spectra obtained on a Bruker DMX500 spectrometer (500 MHz) (solvent
signal centered at δ7.24)
@ Spectra obtained in D2O
usp: under solvent peak
1* 2# 4 5
C-1 39.1 38.4 34.8 38.4
C-2 68.9 68.6 71.2 67.7
C-3 68.6 64.9 65.4 67.5
C-4 33.3 31.8 31.2 31.5
C-5 55.8 50.7 50.5 50.7
C-6 206.7 203.3 202.0 202.3
C-7 122.7 121.8 123.1 123.1
C-8 165.7 162.7 160.4 160.5
C-9 42.9 42.0 38.2 38.2
C-10 39.9 38.8 39.3 39.3
C-11 69.5 72.0 71.2 71.1
C-12 43.8 42.6 37.4 37.5
C-13 ca49 47.3 46.9 47.2
C-14 84.9 83.9 84.2 84.1
C-15 31.9 31.0 31.7 31.7
C-16 21.5 20.5 20.4 20.5
C-17 50.4 48.8 48.8 49.3
C-18 18.9 18.0 18.0 18.0
C-19 24.6 23.9 23.9 23.8
C-20 77.8 76.2 76.8 76.6
C-21 21.0 20.6 20.7 21.2
C-22 78.4 76.4 76.4 79.3
C-23 27.4 26.0 26.0 24.8
C-24 42.4 41.1 40.6 40.2
C-25 71.3 70.0 71.0 70.6
C-26 29.7 29.5 30.0 30.2
C-27 29.0 29.3 29.5 28.7
acetyl-CH3 - 21.1 21.4 21.1
21.2 21.7
acetyl>C=O - 170.6 170.3 170.3
170.0 172.4
14a
#$ 14b
@ 14c 14d
* 14e 14f 14g 14h
1ax-H 1.42 1.39
1eq-H 1.72 1.70
2ax-H 4.00 3.90 4.06 4.04 4.07 4.06 4.06 4.06
3eq-H 3.97 3.85 4.08 4.06 4.09 4.08 4.08 4.08
4ax-H 1.64 1.66
4eq-H 1.83 1.86
5-H 2.42 2.40 2.40 2.40
7-H 5.87 5.81 5.91 5.89 5.92 5.92 5.92 5.92
9-H 3.47 3.14 3.32 3.30 3.33 3.32 3.32 3.33
11-H 5.32 5.12 5.33 5.31 5.33 5.32 5.32 5.33
12ax-H 2.35 2.35
12eq-H 2.16 2.05
15a-H 2.03 2.05
15b-H 1.49 1.53
16a-H 2.11 2.06 2.35 2.35
16b-H 1.89 1.75
17-H 2.45 2.34 2.35 2.36
18-Me 0.92 0.680* 0.926 0.9 0.93 0.93 0.93 0.932
19-Me 1.02 0.835* 1.069 1.05 1.07 1.07 1.07 1.073
21-Me 1.17 0.997* 1.214 1.19 1.22 1.21 1.22 1.221
22-H usp 3.25 3.42 3.41 3.44 3.43 3.43 3.44
23a-H 1.32 1.36
23b-H 1.67 1.60
24a-H 1.75 1.72
24b-H 1.45 1.60
26-Me 1.19 0.986* 1.262 1.242 1.27 1.26 1.26 1.26
27-Me 1.20 0.986* 1.258 1.237 1.27 1.26 1.26 1.26
Acyl-CH3 2.11 0.911 0.978 0.884 0.88 0.88 0.88 0.886
Acyl-CH2- 2.34 2.33 2.35 2.35 2.36
1.67
1.32
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anhydride (400 µL). The reaction was stirred at room temperature
for 2 hours and quenched with H2O (20 mL). After SPE purification,
the 100% MeOH fraction was dried and the residue dissolved in
dioxan (2 mL) and aqueous HCl (0.1M, 1 mL). The reaction mixture
was stirred at room temperature for 4 hours and diluted with H2O
(20 mL). The product was pre-purified on a SPE cartridge and
analysed by HPLC using an ODS2 analytical column with detection
at 242 and 300 nm (30 %-100 % MeOH linear gradient over 30
minutes; 1 mL/min; Rt (12) = 24.4 min, Rt (14b) = 11.2 min). The
product was purified on an ODS2 semi-preparative column (MeOH/
H2O [45:55 v/v], 2 mL/min) and yielded turkesterone 11α-
propionate (14b: 924 µg; 1.7 µmol; 17 % yield). The product was
identified by 1H NMR and mass spectrometry.
CIMS: 570 ([M+NH4]+, 39%), 552 ([M]+, 5%), 496 ([M+H-C3H5O]+,
90%), 479 ([M+H-C3H6O2]+, 100%), 461 ([M+H-C3H6O2-H2O]+,
4%), 443 ([M+H-C3H6O2-2H2O]+, 4%), 425 (2%), 380 (2%), 345
(1%)
1H NMR: see Table 3.
iii) turkesterone 11α-butanoate (14c)
To a solution of 2,3-isopropylidene turkesterone 20,22-
phenylboronate (12: synthesised from 10 mg turkesterone [1]) in
dry pyridine (800 µL) at room temperature was added butanoic
anhydride (400 µL). The reaction was stirred at room temperature
for 6 hours and then heated to 500C for 3 hours, after which time
the reaction appeared to be complete by TLC analysis. The mixture
was diluted with H2O (20 mL) and pre-purified on a SPE cartridge,
leaving the sample in methanol. This was dried under nitrogen and
the residue was dissolved in dioxan (2 mL) and aqueous HCl (0.1M,
1 mL). The reaction mixture was stirred at room temperature for 4
hours and diluted with H2O (20 mL). The product was pre-purified
on a SPE cartridge and analysed by HPLC using an ODS2 analytical
column with detection at 242 and 300 nm (30% - 100% MeOH
linear gradient over 30 minutes, 1 mL/min, Rt (12) = 24.4 min, Rt
(14c) = 12.5 min). The product was purified on an ODS2 semi-
preparative column (MeOH/H2O [50:50 v/v], 2 mL/min) and yielded
turkesterone 11α-butanoate (14c: 1.8 mg; 3.1 µmol; 16 % yield).
The product was identified by 1H NMR and mass spectrometry.
CIMS: 584 ([M+NH4]+, 100%), 566 ([M] +, 8%), 548 ([M-H2O] +,
2%), 496 ([M+H-C4H7O]+, 58%), 479 ([M+H-C4H8O2]+, 72%), 461
([M+H-C4H8O2-H2O]+, 6%), 443 ([M+H-C4H8O2-2H2O]+, 3%), 344
(2 %), 246 (7%)
1H NMR: see Table 3.
iv) turkesterone 11α-hexanoate (14d)
2,3-Isopropylidene turkesterone 20,22-phenylboronate (12:
synthesised from 10 mg turkesterone 1) was dissolved in pyridine/
benzene 6:5, v/v (4 mL) and hexanoic anhydride (335 µL) was
added. After incubation at 500C for 20 hours, the reaction mixture
was reduced to dryness by rotary evaporation. The residue was
dissolved in DCM and fractionated by silica gel chromatography.
Aliquots of each fraction were analysed by TLC (CHCl3/EtOH 9:1
v/v; Rf = 0.76). Fractions containing 2,3-isopropylidene turkesterone
20,22-phenylboronate 11-hexanoate were dried and redissolved in
dioxan (2 mL) and aqueous HCl (0.1M, 1 mL). The reaction mixture
was stirred at room temperature for 4 hours and diluted with H2O
(20 mL). The product was pre-purified on a SPE cartridge and
analysed by HPLC using an ODS2 analytical column with detection
at 242 and 300 nm (30%-100% MeOH linear gradient over 30
minutes; 1 mL/min; Rt (12) = 24.4 min, Rt (14d) = 17.17 min). The
product was purified on an ODS2 semi-preparative column (MeOH/
H2O [60:40 v/v], 2 mL/min) and yielded turkesterone 11α-hexanoate
Table 4. 13C NMR data for turkesterone 11α-acyl analogues
# spectrum obtained on a Bruker Advance DRX400 spectrometer (100 MHz)
in CD3OD
* spectra obtained on a Varian Unity 300 spectrometer (75 MHz) in CDCl3
& spectra obtained on a Bruker Advance DMX500 spectrometer (125 MHz)
in CDCl3
usp: under solvent peak
14a
# 14d* 14f
&
C-1 37.54 38.37 38.39
C-2 67.31 67.65 67.63
C-3 67.21 67.41 67.46
C-4 31.39 31.50 31.50
C-5 51.06 50.67 50.68
C-6 203.90 202.4 202.34
C-7 122.14 123.07 123.08
C-8 162.79 160.60 160.54
C-9 38.29 38.24 38.26
C-10 38.88 39.28 39.30
C-11 71.37 70.79 70.90
C-12 37.48 37.40 37.41
C-13 usp 47.00 47.02
C-14 83.05 84.25 84.27
C-15 30.30 31.79 31.90
C-16 20.11 20.39 20.40
C-17 48.97 48.82 48.85
C-18 17.11 17.95 17.96
C-19 22.98 23.81 23.79
C-20 76.22 usp usp
C-21 20.26 20.69 20.69
C-22 76.96 76.44 76.40
C-23 25.92 26.00 26.02
C-24 40.94 40.66 40.67
C-25 69.88 70.92 70.85
C-26 28.30 29.97 29.98
C-27 27.52 29.45 29.44
acyl-CH3 19.53 13.94 14.11
acyl>C=O 170.88 173.09 173.07
acyl-CH2- - 34.71 34.77
31.33 31.50
24.28 24.63
22.34 22.68
29.60(x2)
29.49
20.32(x2)
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(14d: 5.72 mg; 9.6 µmol; 48% yield). The product was identified
by 1H and 13C NMR and mass spectrometry.
CIMS: 612 ([M+NH4]+, 2%), 597 ([M+H]+, 2%), 579 ([M+H-H2O]+,
5%), 561 ([M+H-2H2O]+, 6%) 543 ([M+H-3H2O]+, 21%), 496 ([M-
C6H11O]+, 4%), 479 ([M+H-C6H12O2]+, 62%), 461 ([M+H-C6H12O2-
H2O]+, 71%), 443 ([M+H-C6H12O2-2H2O]+, 33%), 427 (27%), 362
(35%), 345 (54%), 299 (5%), 178 (11%), 160 (13%), 143 (13%)
1H and 13C NMR: see Tables 3 and 4.
v) turkesterone 11α-decanoate (14e)
The production of turkesterone 11α-decanoate was
completed as for 14d, but using decanoic anhydride (474 mg). The
product was pre-purified on  a SPE cartridge and analysed by HPLC
using an ODS2 analytical column with detection at 242 and 300 nm
(30% - 100% MeOH linear gradient over 30 minutes; 1 mL/min; Rt
(12) = 24.4 min, Rt (14e) = 24.4 min). The product was purified on
an ODS2 semi-preparative column (MeOH/H2O [60:40 v/v], 2 mL/
min) and yielded turkesterone 11α-decanoate (14e: 4.48 mg; 6.9
µmol; 34% yield). The product was identified by mass spectrometry.
CIMS: 669 ([M+NH4-]+, 1%), 651 ([M+H]+, 1%), 634 ([M+H-H2O]+,
1.5%), 616 ([M+H-2H2O]+, 1.5%), 479 ([M+H-C10H20O2]+, 81%),
461 ([M+H-C10H20O2-H2O]+, 80%), 443 ([M+H-C10H20O2-2H2O]+,
57%), 425 (35%), 361 (32%), 345 (47%), 256 (14%), 190 (44%),
143 (28%)
vi) turkesterone 11α-laurate (14f)
The production of turkesterone 11α-laurate was completed
as for 14d, but using lauric anhydride (555 mg). The product was
pre-purified on a SPE cartridge and analysed by HPLC using an
ODS2 analytical column with detection at 242 and 300 nm (30% -
100% MeOH linear gradient over 30 minutes; 1 mL/min; Rt (12) =
24.4 min, Rt (14f) = 26.8 min). The product was purified on an
ODS2 semi-preparative column (MeOH/H2O [60:40 v/v], 2 mL/
min) and yielded turkesterone 11α-laurate (14f: 1.47 mg; 2.2 µmol;
11% yield). The product was identified by 1H and 13C NMR and
mass spectrometry.
FABMS: 701 ([M+Na]+, 11%), 661 ([M+H-H2O]+, 6%), 643 ([M+H-
2H2O]+, 9%), 625 ([M+H-3H2O]+, 6%), 565(11%), 479 ([M+H-
C12H24O2]+, 82%), 461 ([M+H-C12H24O2-H2O]+, 16%), 443 ([M+H-
C12H24O2-2H2O]+, 16%), 425 ([M+H-C12H24O2-3H2O]+, 18%), 391
(70%), 369 (36%).
1H and 13C NMR: see tables 3 and 4
vii) turkesterone 11α-myristate (14g)
The synthesis of turkesterone 11α-myristate was completed
as for 14d, but using myristic anhydride (635 mg). The deprotection
reactions were diluted with H2O as before, but this brought about
precipitation of the products. The sample was centrifuged and the
supernatant removed. The pellet was redissolved in methanol and
analysed by HPLC using an ODS2 analytical column with detection
at 242 and 300 nm (80 %-100 % MeOH linear gradient over 20
minutes; 1 mL/min; Rt (14g) = 9.1 min). The product was purified
on an ODS2 semi-preparative column (MeOH/H2O, 90:10 v/v, 2
mL/min) and yielded turkesterone 11α-myristate (14g: 1.3 mg; 1.9
µmol; 9 % yield). The product was identified by 1H NMR and mass
spectrometry.
FABMS: 730 ([M+Na]+, 15%), 689 ([M+H-H2O]+, 14%), 672
([M+H-2H2O]+, 24%), 654 ([M+H-3H2O]+, 17%), 493 (9%), 479
([M+H-C14H28O2]+, 100%), 461 ([M+H-C14H28O2-H2O]+, 66%), 443
([M+H-C14H28O2-2H2O]+, 52%), 425 ([M+H-C14H28O2-3H2O]+,
55%), 391 (62%), 362 (30%), 345 (40%), 327 (32%), 309 (96%),
299 (67%), 281 (55%), 228 (92%), 211 (30%)
1H NMR: see Table 3.
viii) turkesterone 11α-arachidate (14h)
The synthesis of turkesterone 11α-arachidate was
Table 5. Biological activities of natural and synthetic ecdysteroids
n.d.: not determined
n.c.: not calculated
Table 6. Comparison between EC50 values determined in the BII bioassay
and Kd values in cell-free extracts of BII cells for a range of ecdysteroids and
two bisacylhydrazines. See Lafont et al. (2002) for the structures of the
unnumbered ecdysteroids.
* values taken from Clément et al, (1993) or Dinan et al. (1999)
DmEcR/DmUSP BIIBioassay
Ecdysteroid IC50 Ki EC50
20-hydroxyecdysone(6) 1.2x10
-7M 5.2x10
-8M 7.5x10
-9M
turkesterone(1) 2.1x10
-7M 9.0x10
-8M 8.0x10
-7M
turkesterone11-acetate(14a) 7.8x10
-6M 3.3x10
-6M 4.0x10
-6M
turkesterone11D-propionate(14b) 2.4x10
-5M 1.0x10
-5M 8.3x10
-6M
turkesterone11D-butanoate(14c) 9.1x10
-5M 3.9x10
-5M 4.0x10
-5M
turkesterone11D-hexanoate(14d) 7.0x10
-5M 3.0x10
-5M 2.2x10
-5M
turkesterone11D-decanoate(14e) 2.7x10
-5M 1.2x10
-5M 1.1x10
-6M
turkesterone11D-laurate(14f)n d 3.4x10
-6M
turkesterone11D-myristate(14g)n d 1.3x10
-6M
turkesterone11D-arachidate(14h) >10
-4M n.c. 2.2x10
-5M
turkesterone2-acetate(2) 5.2x10
-6M 2.9x10
-6M 5.2x10
-6M
turkesterone2,11D-diacetate(4) n.d. 2.0x10
-4M
turkesterone2,22-diacetate(5) n.d. 1.0x10
-3M
Ecdysteroid EC50value* Kdvalue Kd/EC50
ponasteroneA(7) 3.1x10
-10M 7.2x10
-10M2 . 3
ajugasteroneC(8) 3.0x10
-8M 1.3x10
-9M 0.04
muristeroneA(9) 2.2x10
-8M 2.2x10
-9M0 . 1
25-fluoro-20-hydroxyecdysone 5.1x10
-9M 5.2x10
-9M1 . 0
polypodineB 1.0x10
-9M 7.7x10
-9M7 . 7
5-deoxykaladasterone 5.2x10
-10M 1.0x10
-8M 19.2
abutasterone 1.4x10
-7M 1.1x10
-8M 0.08
cyasterone 1.2x10
-8M 1.7x10
-8M1 . 4
20-hydroxyecdysone(6) 7.5x10
-9M 2.5x10
-8M3 . 3
inokosterone 1.1x10
-7M 3.5x10
-8M 0.17
makisteroneA 1.3x10
-8M 6.4x10
-8M4 . 9
turkesterone(1) 1.3x10
-6M 1.4x10
-7M 0.11
RH5992 5.3x10
-7M 2.1x10
-7M0 . 4
ajugalactone 1.6x10
-7M 3.1x10
-7M 0.19
RH5849 1.8x10
-6M 1.5x10
-7M 0.08
ecdysone 1.1x10
-6M 1.7x10
-6M 1.55
2-deoxyecdysone 5.0x10
-5M 3.8x10
-6M 0.08
22-epi-ecdysone 5.3x10
-6M 6.7x10
-6M 1.26
poststerone 2.0x10
-5M 1.5x10
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completed as for 14g, but using arachidic anhydride (880 mg). The
deprotection reactions were diluted with H2O, but this brought about
precipitation of the products. The sample was centrifuged and the
supernatant removed. The pellet was redissolved in methanol and
analysed by HPLC using an ODS2 analytical column with detection
at 242 and 300 nm (80 %-100 % MeOH linear gradient over 20
minutes; 1 mL/min; Rt (14h) = 19.2 min). The product was purified
on an ODS2 semi-preparative column (MeOH/H2O, 95:5 v/v, 2 mL/
min) and yielded turkesterone 11α-arachidate (14h: 2.6 mg; 3.3
µmol; 16% yield). The product was identified by 1H NMR and mass
spectrometry.
CIMS: 809 ([M+NH4-]+, 7%), 790 ([M]+, 8%), 479 ([M+H-
C20H40O2]+, 55%), 461 ([M+H-C20H40O2-H2O]+, 55%), 443 ([M+H-
C20H40O2-2H2O]+, 34%), 428 (34%), 363 (47%), 346 (65%), 331
(34%), 283 (15%), 141 (36%).
1H NMR: see Table 3.
Synthesis of turkesterone acetates
Conversion of turkesterone (1) to turkesterone 2-monoacetate (2)
To a solution of turkesterone (1: 5 mg; 10.4  µmol) in dry
pyridine (400  µL) at room temperature was added acetic anhydride
(200 µL; 2.08 mmol; 200 eq.). The reaction was stirred at room
temperature for 1 hour and quenched with H2O (20 mL). The residue
was pre-purified on a SPE cartridge and analysed by HPLC using
an ODS2 analytical column with detection at 242 and 300 nm (30%-
100% MeOH linear gradient over 30 minutes, 1 mL/min; Rt (1) =
6.3 min, Rt (2) = re8.4 min]. The product was purified on an ODS2
semi-preparative column (MeOH/H2O [45:55 v/v], 2 mL/min) and
yielded turkesterone 2-acetate (2: 613 µg; 1.1 µmol; 12%). The
product was identified by mass spectrometry.
CIMS: 557 ([M+NH4]+, 62%), 539 ([M+H]+, 32 %), 522 ([M+H-
H2O]+, 61%), 486 ([M+H-3H2O]+, 65%), 462 (40%), 444 (33%),
439 (74%), 423 (84%), 405 (47%), 362 (32%), 344 (28%), 328
(16%), 178 (18%), 160 (18%).
Conversion of turkesterone (1) to turkesterone 2,11-diacetate (4)
To a solution of turkesterone (1: 10 mg; 20.8 µmol) in dry
pyridine (800 µL) at room temperature was added acetic anhydride
(400 µL; 4.16 mmol; 200 eq.). The reaction was stirred at room
temperature for 1 hour and quenched with the addition of H2O (20
mL). The residue was pre-purified on a SPE cartridge and analysed
by HPLC using an ODS2 analytical column with detection at 242
and 300 nm (30%-100% MeOH linear gradient over 30 minutes; 1
mL/min; Rt (1) = 6.3 min, Rt (4) = 11.3 min). The product was
purified on an ODS2 semi-preparative column (MeOH/H2O [45:55
v/v], 2 mL/min) and yielded turkesterone 2,11-diacetate (4: 5.6 mg;
9.7 µmol; 48% yield). The product was identified by 1H and 13C
NMR and mass spectrometry.
CIMS: 598 ([M+NH4]+, 8%), 580 ([M]+, 6%), 563 ([M+H-H2O]+,
10%), 545 ([M+H-2H2O]+, 31%), 538 ([M-Ac]+, 12%), 485 ([M+H-
Ac-3H2O]+, 48%), 480 ([M-2Ac-H2O]+, 28%), 464 (70%), 420
(38%), 404 (82%), 387 (100%), 344 (24%), 325 (16%), 128 (65%)
1H and 13C NMR: see Tables 1 and 2.
Conversion of 2,3-isopropylidene turkesterone (10) to turkesterone
11,22-diacetate (5)
To a solution of 2,3-isopropylidene turkesterone (10:
synthesised from 10 mg turkesterone [1]) in dry pyridine (800  µL)
at room temperature was added acetic anhydride (400 µL). The
reaction was stirred at room temperature for 3 hours and quenched
with H2O (20 mL). The reaction mixture was pre-purified on a SPE
cartridge and the 100% MeOH fraction dried under nitrogen. The
residue was dissolved in dioxan (2 mL) and aqueous HCl (0.1M, 1
mL). The reaction mixture was stirred at room temperature for 4
hours and was diluted by the addition of H2O (20 mL). The product
was pre-purified on a SPE cartridge and analysed by HPLC using
an ODS2 analytical column with detection at 242 and 300 nm (30%
- 100% MeOH linear gradient over 30 minutes, 1 mL/min, Rt (10)
= 12.5 min, Rt (5) = 11.2 min). The product was purified on an
ODS2 semi-preparative column (MeOH/H2O [45:55 v/v], 2 mL/
min) and yielded turkesterone 11,22-diacetate (5: 5.4 mg, 9.3 µmol,
46% yield). The product was identified by 1H and 13C NMR and
mass spectrometry.
CIMS: 598 ([M+NH4]+, 27%), 563 ([M+H-H2O]+, 8%), 545 ([M+H-
2H2O]+, 5%), 538 ([M-Ac]+, 5%), 521 ([M+H-Ac-H2O]+, 100%),
503 ([M+H-Ac-2H2O]+, 40%), 485 ([M+H-Ac-3H2O]+, 22%), 461
(18%), 443 (35%), 425 (41%), 344 (19%), 176 (20%), 136 (52%),
128 (25%).
1H and 13C NMR: see Tables 1 and 2.
Purity of test compounds
All compounds for bioassay were purified by RP-HPLC
using water/methanol mixtures. Purity of samples for bioassay was
>98%.
BII bioassay
The microplate-based BII bioassay, based on the ecdysteroid-
responsive D. melanogaster l(2)mbn permanent cell line, was
performed as described previously (Clément et al., 1993).
Competitive radioligand binding assay with in vitro-expressed
receptor complexes
Bacterially-expressed DmEcR and DmUSP proteins were
used in a competitive binding assay with [24,25,26,27-
3H]ponasterone A (0.2 nM; 150 Ci/mmol; ARC Inc.) as previously
described (Dinan et al., 2001). Ki values were calculated from IC50
values by means of the Cheng-Prusoff equation (Ki = IC50/{1 +
[radiolabelled ligand]/Kd}; Cheng and Prusoff, 1973), with the Kd
for [3H]ponA being 0.15 nM.
Extraction of receptor complexes from BII cells and cell-free receptor
assays
Ecdysteroid receptor complexes were extracted from BII
cells by sonication as described previously (Dinan, 1985). After
centrifugation (20,000 x g for 30 min), aliquots of the supernatant
were incubated with [3H]ponA (0.2 nM; 183 Ci/mmol) and known8 Dinan L, Bourne P, Whiting P, Tsitekli A, Saatov Z, Dhadialla TS, Hormann RE, Lafont R, Coll J. 2002.  Synthesis and biological activities of
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concentrations of the test compounds. Specifically-bound radiolabel
was determined by dextran-coated charcoal assay (Dinan, 1985).
Kd values were determined by the LIGAND program.
Results and Discussion
Regioselective synthesis of 11α-acyl derivatives of turkesterone
Owing to the presence of several reactive secondary
hydroxyl groups in turkesterone, it was necessary to protect the
diols at C-2/C-3 and C-20/C-22 in order to selectively acylate the
11α-hydroxyl. The acylation sequence of the hydroxyls in 20-
hydroxyecdysone has been investigated previously (Galbraith and
Horn, 1969) and found to be: 2>22>3>>25. Acetylation experiments
comparing turkesterone and 20-hydroxyecdysone indicated that the
sequence for turkesterone was 2>11>22>3>>25 (data not shown).
Figure 2 demonstrates the protection strategy employed. The 20,22-
phenylboronate was first produced, followed by the 2,3-acetonide
derivative. The 11α-hydroxyl group could then be derivatised with
the appropriate acyl anhydride. Conditions for this reaction had to
be modified to take account of the solid state and lower solubility
of the higher acyl anhydrides relative to their lower homologues.
The diol-protecting groups were readily removed with dilute acid.
Overall yields for the 11α-acyl derivatives were variable. The
synthesis of turkesterone 11α-benzoate was attempted, but the
product proved unstable, degrading rapidly back to turkesterone.
Identification of turkesterone derivatives
Turkesterone derivatives were identified by a combination
of 1H and 13C NMR and mass spectrometry. The major distinctive
1H-NMR features amongst the compounds were the presence of
one or more singlet absorptions at ca. δ 2.0 due to the acetyl groups
for the acetates, and the shifts of ca. 1 ppm for the acylated
oxymethine in acyl analogues. In the homogeneous series of 11α-
acyl analogues, significant differences were only observed in the
number of signals in the 13C-NMR associated with the length of the
acyl chain. Diagnostic absorptions are reported for all compounds
and selected representatives were fully characterized by NMR.
Minor differences were observed in the 11-O-acyl series and the
expected shifts upon acylation of other positions.
1H NMR for 11α-acyl derivatives
The most noticeable change from the spectrum for
turkesterone was the shift in the H-11 signal from δ4.1 to δ5.3. The
signal for the acyl methyl (CH3) was present at δ0.8-0.9 and signals
at δ1.3-2.3 related to the acyl CH2 groups.
13C NMR for 11α-acyl derivatives
A small shift in the C-11 signal from δ69.5 in turkesterone
to δ71-72 was apparent for all acyl derivatives. The acyl carbonyl
(C=O) was identified by a signal at δ171-173, the acyl methyl was
identified by a signal at δ14 and the acyl CH2 groups were identified
by a sequence of signals around δ22-35.
1H NMR for acetate derivatives
2ax-H and 3eq-H seen at δ4.01 and δ3.95, respectively, in
turkesterone displayed downfield shifts to δ5.1-5.3 and δ4.1-4.2,
respectively, upon derivatization at C-2. Similarly the peak for 11-
H seen at δ4.1 in turkesterone was seen at δ5.3-5.6 in derivatives
containing an acetate at C-11, and the signal for 22-H, seen at δ3.44
in turkesterone, shifted to δ4.8 upon derivatization at C-22. Acetyl
(CH3) signals were apparent at δ2.0-2.1.
13C NMR for acetate derivatives
Only minor shifts were observed for signals corresponding
to C-2, C-3, C-11 and C-22 for compounds derivatised at C-2, C-11
and/or C-22 (from δ68.9, 68.6, 69.5 and 78.4 for turkesterone to
δ71.2, 65, 71 and 79, respectively, for derivatised compounds). The
acetyl carbonyl (C=O) was the most obvious addition to the spectra
at ca. δ170 while the acetyl (CH3) signals could be identified at ca.
δ21.
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Figure 2. Scheme for the synthesis of turkesterone 11α-acyl derivatives: i)
phenylboronic acid, dry DMF, r.t. 2 h, ii) addition of dry DMP, dry acetone
and fused p-TsOH, r.t. 3h, iii) R-COOCO-R, dry pyridine (or pyridine/
benzene 6:5 v/v), r.t. (or 50oC) for 2-20 h and iv) 0.1M HCl/dioxan (1:1 v/
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Biological activity of turkesterone 11α-acyl derivatives
BII bioassay: The biological activity of turkesterone in the
BII bioassay is ca. 100-fold lower than that of 20E (Table 5). It is
notable that all the tested derivatives of turkesterone retain
quantifiable biological activity in this bioassay, but their activities
range from almost identical to over 1000-fold less than that of
turkesterone. When one compares the activities of the various 11α-
acyl homologues, biological activity initially decreases with
increasing acyl chain length (C2 to C4) with the acetate, propionate
and butanoate being 5-, 10- and 50-fold less active than turkesterone.
However, with intermediate length acyl groups (C6 to C14) the activity
increases again, such that the activities of the 11α-decanoate, -laurate
and -myristate are similar to that of turkesterone. Activity is again
lower with the C22 arachidate ester (27.5-fold lower than
turkesterone). These data indicate that the ligand binding pocket of
EcR is capable of accepting steric bulk around C-11 of the
ecdysteroidal ligand and that, further, interaction between the ligand
and the binding pocket is enhanced with medium-chain length acyl
groups (C10 - C14), relative to short- and long-chain acyl derivatives.
Turkesterone 2-acetate has a biological activity similar to that of
turkesterone 11α-acetate, in accord with previous observations that
small substituents at C-2 lower activity, but do not abolish it. The
diacetates, 2,11- and 2,22-, have very much lower activities than
turkesterone, but the 2,11-diacetate is more active than the 2,22-
diacetate, again revealing that derivatisation at 11α is less
detrimental than at C-22.
In vitro receptor assays: In addition to receptor affinity, a
number of factors (e.g. penetration into the cells, sequestration,
hydrolysis of ester-containing compounds) might affect potency in
the BII bioassay. Consequently, the ability of certain of the test
compounds to displace [3H]ponA from in vitro-expressed DmEcR/
DmUSP receptor complex was assessed (Table 5). Owing to limited
quantities of the DmEcR and DmUSP proteins, it was not possible
to assess all of the analogues. Comparison of the receptor assay
with the BII bioassay reveals a distinct difference between 20E and
turkesterone. While 20E is more potent in the BII bioassay (EC50 =
7.5 x 10-9M) than in the receptor assay (Ki = 5.2 x 10-8M),
turkesterone is, conversely, ca. 9-fold less potent in the BII bioassay
(EC50 = 8.0 x 10-7M) than in the receptor assay (Ki = 9.0 x 10-8M).
This implies that other factors (entry, efflux, sequestration or
metabolism) affect turkesterone and 20E differentially. It is known
that the BII cells do not metabolise 20E (Dinan, 1985). The
differential activities in the two systems may relate to previous
findings that turkesterone is a potent ecdysteroid in some insect
systems, but not in others (Sláma et al., 1993). Alternatively, it may
indicate that the in vitro preparation has the capacity to dehydrate
11α-hydroxyl ecdysteroids to 7,9(11)-dien-6-ones (which are known
to be biologically active) by a chemical reaction which occurs readily
(Bourne et al., 2002).
However, there is good agreement between the Ki and EC50
values for the 11α-acyl derivatives of turkesterone and, as far as
the somewhat restricted range of analogues assessed permits, the
activity pattern in the receptor assay is similar to that in the BII
bioassay with the activity decreasing with increasing acyl length
from C2 to C4 and then increasing again with C6 and C10 acyl
derivatives. The C20 derivative has a very low activity. There is also
good agreement between the Ki and EC50 values for turkesterone 2-
acetate. Thus, although these data reveal inconsistencies for
turkesterone and 20E, they support the notion that steric bulk can
be accommodated around C-11 of the ecdysteroid within the ligand
binding pocket of EcR.
Since the receptor complex almost certainly consists of
other protein components in addition to EcR and USP, which are
unlikely to be present in the in vitro translated complexes, we include
data (Table 6) on the comparison of the structure-activity
relationships for the BII bioassay and a cell-free receptor assay based
on ecdysteroid receptor complexes extracted from BII cells, where
other endogenous transcription factors and binding proteins could
be part of the extracted receptor complex. In general, there is
reasonable agreement between the EC50 and Kd values determined
for most of the compounds. However, it is noticeable that the three
11α-hydroxy compounds included here (ajugasterone C,
muristerone A and turkesterone) all have very low Kd/EC50 ratios,
as seen above for turkesterone in the comparison of the BII bioassay
and in vitro-expressed DmEcR/DmUSP.
Implications
Enhanced activity of 25-deoxy compounds: With the D.
melanogaster BII bioassay and in vitro DmEcR/DmUSP receptor
assays, turkesterone shows considerably lower activity than 20E,
although in other systems turkesterone is apparently more potent.
Turkesterone was used in this study as a model compound, because
it was the most readily available ecdysteroid possessing an 11α-
hydroxyl group. However, to exploit the potential of 11α-derivatives
it would be preferable to use higher potency analogues lacking the
25-hydroxyl group e.g ajugasterone C (EC50 = 3.0 x 10-8M) or
muristerone A (EC50 = 2.2 x 10-8M), which should generate 11α-
derivatives with ca. 100-fold greater activity than those listed in
Table 5.
Future synthesis of 11β-acyl derivatives: It would be
desirable to synthesise a parallel series of 11β-acyl derivatives in
order to compare their activities to those of the 11α-acyl analogues.
Realisation of this goal will be complicated by the absence of any
known 11β-hydroxy ecdysteroids (Lafont et al., 2002) and the ready
tendency of 11α-hydroxy ecdysteroids to dehydrate, generating
7,9(11)-dien-6-ones, under a variety of chemical conditions
(Canonica et al., 1977; Qui and Nie, 1983; Bourne et al., 2002),
making sequential oxidation and reduction of the 11-hydroxyl group
difficult.
Relationship to other steroid hormones: The availability
of hydrophobic space in the ligand-binding pocket in the region of
C-11 of the steroid appears to be a common feature of steroid
hormone receptors. 11β-Amidoalkoxyphenyl estradiols are potent
antioestrogens (Nique et al., 1994). The hydrophobic pocket has
been exploited to develop 11β-substituted 19-norsteroids as
fluorescent steroid derivatives for the glucocorticoid and
progesterone receptors (Teutsch et al., 1994). The antiprogesterone10 Dinan L, Bourne P, Whiting P, Tsitekli A, Saatov Z, Dhadialla TS, Hormann RE, Lafont R, Coll J. 2002.  Synthesis and biological activities of
turkesterone 11α-acyl derivatives.  11pp.  Journal of Insect Science, 3:6, Available online: insectscience.org/3.6
RU486 (mifepristone), used as an abortifacient, is an 11β-aryl-19-
nor steroid (Rosen et al., 1995).
Application for synthesis of tagged ecdysteroids: The
studies shown here reveal that there is considerable steric space in
the ligand binding pocket of DmEcR extending out from C-11 of
the ecdysteroid, as was predicted from the CoMFA models. This
area would thus be a good candidate for the preparation of tagged
ecdysteroids, for example the attachment of a fluorescent moiety
for the generation of an alternative, non-radioactive receptor assay
ligand. Currently, [3H]ponA is almost exclusively used as the ligand
for receptor assays, but it is expensive and, owing to its very high
specific activity (120 - 180 Ci/mmol), requires regular repurification.
C-11 could also be a good location for an affinity labelling moiety
as an alternative to the photoreactive endogenous ∆7-en-6-one
(Schaltmann and Pongs, 1982) or an extended conjugated system
(7,9[11]-dien-6-one; Bourne et al., 2002). For example,
bromoacetate derivatives have proved effective electrophilic affinity
agents for vitamin D binding protein (Swamy et al., 2000) and the
human progesterone receptor (Holmes et al., 1981). Also, a
successful photoaffinity label for human multidrug resistance protein
has been based on the steroid agosterol A (Ren et al., 2001), which
is structurally similar to ecdysteroids and possesses an 11α-hydroxyl
group, on to which the azidophenyl photoaffinity label is attached.
Further, it has been found that insect EcR proteins when expressed
in mammalian cells and partnered by RXR have altered ligand
specificity and affinity, such that 20E, the endogenous hormone in
insect systems, is virtually inactive. However, muristerone A,
possessing an 11α-hydroxyl group, is active, but micromolar
concentrations are required. For gene switching it would be highly
desirable to identify ecdysteroids with higher affinity than
muristerone A. Production of 11α-derivatives may enhance affinity
by providing closer contact to the ligand binding pocket.
Conclusion
The prediction from CoMFA modelling of ecdysteroid
QSAR data that the ligand binding domain of D. melanogaster EcR
proteins possesses a hydrophobic pocket in the vicinity of C-11 of
the steroid is substantiated by the biological activity of a series of
11α-acyl derivatives of turkesterone. All the 11α-acyl derivatives
retain some biological activity and activity is higher with medium-
chain acyl derivatives. The presence of a hydrophobic pocket in
this region is a feature shared with several other steroid hormone
receptors. The presence of this pocket may be exploited to generate
fluorescently-tagged and affinity-labelled ecdysteroids which retain
high biological activity.
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